Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: Analysis of 1502 cases

British Journal of Haematology

Volumn 167, Issue 2, 2014, Pages 224-232

  Gentile, Massimo ^a   Mauro, Francesca R ^b   Rossi, Davide ^c   Vincelli, Iolanda ^d   Tripepi, Giovanni ^e   Recchia, Anna G ^f   De Stefano, Laura ^f   Campanelli, Melissa ^b   Giannarelli, Diana ^g   Bossio, Sabrina ^f   Morabito, Lucio ^h   Vigna, Ernesto ^a   Gaidano, Gianluca ^c   Foà, Robin ^b   Morabito, Fortunato ^a,f  

^a UOC Ematologia di Cosenza   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d UOC di Ematologia di Reggio Calabria   (Italy)

^e REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^f Azienda Ospedaliera di Cosenza   (Italy)

^g CNR   (Italy)

^h HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Chronic lymphocytic leukaemia; Nomogram; Prognosis; Prognostic index

Indexed keywords

BETA 2 MICROGLOBULIN;

ADULT; AGE; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CORRELATIONAL STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; LOW RISK POPULATION; LYMPH NODE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOCLONAL B CELL LYMPHOCYTOSIS; NOMOGRAM; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; REPRODUCIBILITY; RISK ASSESSMENT; SCORING SYSTEM; SEX; VALIDATION STUDY; VERY ELDERLY; CLINICAL TRIAL; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MULTICENTER STUDY; PATHOLOGY; PROGNOSIS; SURVIVAL;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; NEOPLASM STAGING; NOMOGRAMS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SURVIVAL ANALYSIS;

EID: 84908498872     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13032     Document Type: Article

References (20)

1. Binet, J.L., Auquier, A., Dighiero, G., Chastang, C., Piguet, H., Goasguen, J., Vaugier, G., Potron, G., Colona, P., Oberling, F., Thomas, M., Tchernia, G., Jacquillat, C., Boivin, P., Lesty, C., Duault, M.T., Monconduit, M., Belabbes, S. & Gremy, F. (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer, 48, 198-206.
2. Bulian, P., Tarnani, M., Rossi, D., Forconi, F., Del Poeta, G., Bertoni, F., Zucca, E., Montillo, M., Pozzato, G., Deaglio, S., D'Arena, G., Efremov, D., Marasca, R., Lauria, F., Gattei, V., Gaidano, G. & Laurenti, L. (2011) Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia. Hematological Oncolology, 29, 91-99.
3. Bulian, P., Shanafelt, T.D., Fegan, C., Zucchetto, A., Cro, L., Nückel, H., Baldini, L., Kurtova, A.V., Ferrajoli, A., Burger, J.A., Gaidano, G., Del Poeta, G., Pepper, C., Rossi, D. & Gattei, V. (2014) CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia. Journal of Clinical Oncology, 32, 897-904.
4. Chiorazzi, N. (2012) Implications of new prognostic markers in chronic lymphocytic leukemia. Hematology American Society of Hematology Education Program, 2012, 76-87.
5. Crespo, M., Bosch, F., Villamor, N., Bellosillo, B., Colomer, D., Rozman, M., Marcé, S., López-Guillermo, A., Campo, E. & Montserrat, E. (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. The New England Journal of Medicine, 348, 1764-1775.
6. Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. & Chiorazzi, N. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94, 1840-1847.
7. Dohner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Krober, A., Bullinger, L., Dohner, K., Bentz, M. & Lichter, P. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. The New England Journal of Medicine, 343, 1910-1916.
8. Gentile, M., Mauro, F.R., Calabrese, E., De Propris, M.S., Giammartini, E., Mancini, F., Milani, M.L., Guarini, A. & Foà, R. (2005) The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience. British Journal of Haematology, 130, 549-557.
9. Greipp, P.R., San Miguel, J., Durie, B.G., Crowley, J.J., Barlogie, B., Bladé, J., Boccadoro, M., Child, J.A., Avet-Loiseau, H., Kyle, R.A., Lahuerta, J.J., Ludwig, H., Morgan, G., Powles, R., Shimizu, K., Shustik, C., Sonneveld, P., Tosi, P., Turesson, I. & Westin, J. (2005) International staging system for multiple myeloma. Journal of Clinical Oncology, 23, 3412-3420.
10. Hallek, M., Cheson, B.D., Catovsky, D., Caligaris-Cappio, F., Dighiero, G., Döhner, H., Hillmen, P., Keating, M.J., Montserrat, E., Rai, K.R. & Kipps, T.J. (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood, 111, 5446-5456.
11. Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. & Stevenson, F.K. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood, 94, 1848-1854.
12. Harrell, F.E. Jr, Lee, K.L. & Mark, D.B. (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in Medicine, 15, 361-387.
13. Morabito, F., Cutrona, G., Gentile, M., Matis, S., Todoerti, K., Colombo, M., Sonaglio, C., Fabris, S., Reverberi, D., Megna, M., Spriano, M., Lucia, E., Rossi, E., Callea, V., Mazzone, C., Festini, G., Zupo, S., Molica, S., Neri, A. & Ferrarini, M. (2009) Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia. British Journal of Haematology, 146, 44-53.
14. Rai, K. (1987) A Critical Analysis of Staging in CLL. Alan R. Liss, New York.
15. Rai, K.R., Sawitsky, A., Cronkite, E.P., Chanana, A.D., Levy, R.N. & Pasternack, B.S. (1975) Clinical staging of chronic lymphocytic leukemia. Blood, 46, 219-234.
16. Rassenti, L.Z., Huynh, L., Toy, T.L., Chen, L., Keating, M.J., Gribben, J.G., Neuberg, D.S., Flinn, I.W., Rai, K.R., Byrd, J.C., Kay, N.E., Greaves, A., Weiss, A. & Kipps, T.J. (2004) ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. The New England Journal of Medicine, 351, 893-901.
17. Rozman, C. & Montserrat, E. (1995) Chronic lymphocytic leukemia. The New England Journal of Medicine, 333, 1052-1057.
18. Shanafelt, T.D., Jenkins, G., Call, T.G., Zent, C.S., Slager, S., Bowen, D.A., Schwager, S., Hanson, C.A., Jelinek, D.F. & Kay, N.E. (2009) Validation of a new prognostic index for patients with chronic lymphocytic leukemia. Cancer, 115, 363-372.
19. Solal-Celigny, P., Roy, P., Colombat, P., White, J., Armitage, J.O., Arranz-Saez, R., Au, W.Y., Bellei, M., Brice, P., Caballero, D., Coiffier, B., Conde-Garcia, E., Doyen, C., Federico, M., Fisher, R.I., Garcia-Conde, J.F., Guglielmi, C., Hagenbeek, A., Haïoun, C., LeBlanc, M., Lister, A.T., Lopez-Guillermo, A., McLaughlin, P., Milpied, N., Morel, P., Mounier, N., Proctor, S.J., Rohatiner, A., Smith, P., Soubeyran, P., Tilly, H., Vitolo, U., Zinzani, P.L., Zucca, E. & Montserrat, E. (2004) Follicular lymphoma international prognostic index. Blood, 104, 1258-1265.
20. Wierda, W.G., O'Brien, S., Wang, X., Faderl, S., Ferrajoli, A., Do, K.A., Cortes, J., Thomas, D., Garcia-Manero, G., Koller, C., Beran, M., Giles, F., Ravandi, F., Lerner, S., Kantarjian, H. & Keating, M. (2007) Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia. Blood, 109, 4679-4685.